An IHC stained image of tumor.
An immunohistochemically stained image showcasing tumor tissue.
The image presents tumor tissue visualized through IHC staining.
A histological section stained using IHC, highlighting tumor structures.
An IHC-stained tissue sample displaying tumor morphology.
Tumor cells are observed in this IHC-stained histopathology image.
A high-resolution IHC-stained section highlighting tumor tissue.
This image captures tumor structures stained using immunohistochemical techniques.
An IHC-prepared sample showing tumor tissue distribution.
The image provides an IHC-based visualization of tumor architecture.
A microscopic view of tumor regions stained using IHC markers.

An IHC image of Tumor stained using the CD38 biomarker.
The image presents tumor tissue stained with the CD38 biomarker using IHC techniques.
CD38-stained tumor structures are visualized in this IHC micrograph.
An IHC-stained section highlights tumor tissue marked by CD38.
CD38-positive staining is observed in tumor tissue in this IHC-stained sample.
The immunohistochemistry image features tumor tissue with CD38 expression.
This IHC-stained tissue section reveals tumor structures marked with CD38.
An IHC-stained micrograph of tumor tissue exhibiting CD38 positivity.
The presence of CD38-expressing immune cells is confirmed in tumor tissue through IHC staining.
The image presents tumor structures stained with the CD38 biomarker in an IHC tissue section.
A microscopic view of tumor tissue showing CD38-positive staining through IHC techniques.

Tumor tissue with faint staining is observed, likely indicating minimal immune cell activity.
The image shows tumor tissue with faint staining, suggesting limited immune cell involvement.
Faint staining in tumor tissue indicates minimal immune infiltration.
Tumor structures exhibit weak staining, marking potential immune cell presence.
A low-intensity staining pattern in tumor tissue suggests limited immune response.
Faintly stained regions in tumor tissue may indicate sparse immune cell activity.
The presence of faint staining in tumor structures suggests minimal immune engagement.
A weak staining pattern in tumor tissue marks potential immune suppression.
Tumor tissue presents faint staining, likely representing limited immune interactions.
Minimal staining is observed in tumor sections, suggesting restricted immune cell presence.
The image highlights tumor structures with faint staining, marking a low level of immune involvement.


CD38-positive cells in tumor tissue show faint cytoplasmic staining, likely representing plasma cells or activated immune cells.
CD38-expressing cells in tumor tissue show faint cytoplasmic staining, marking plasma cell or immune activity.
The image presents tumor tissue with weak CD38 staining, suggesting minimal immune engagement.
Faint CD38 staining in tumor tissue highlights plasma cell or activated immune cell presence.
Tumor sections exhibit mild CD38 staining, likely marking immune cell activity.
CD38-positive staining is faint in tumor tissue, suggesting subtle immune involvement.
Weak CD38 staining in tumor-associated immune cells indicates minimal immune activation.
The presence of faintly stained CD38-positive cells suggests a low immune response.
CD38 expression in tumor tissue is observed as faint cytoplasmic staining, marking immune presence.
Tumor sections show low-intensity CD38 staining, highlighting minimal plasma cell infiltration.
CD38-positive cells in tumor tissue display mild staining, confirming limited immune cell activation.


CD38 staining highlights scattered plasma cells or activated immune cells in tumor tissue, with faint cytoplasmic positivity suggesting limited immune engagement within the tumor microenvironment.
CD38 staining in tumor tissue reveals scattered plasma cells or immune cells with faint cytoplasmic expression.
The image highlights CD38-positive cells in tumor tissue, marking dispersed immune cell presence.
A weak CD38 staining pattern in tumor tissue suggests minimal immune infiltration.
Faintly stained CD38-positive plasma cells in tumor tissue indicate limited immune engagement.
CD38 expression in tumor-associated immune cells appears as faint cytoplasmic staining.
Tumor sections exhibit weak CD38 staining, suggesting scattered plasma cells or immune activation.
A mild CD38 staining pattern in tumor tissue marks potential immune response limitations.
Plasma cells or immune cells in tumor structures show faint CD38 staining, marking immune suppression.
The presence of CD38-positive immune cells in tumor tissue suggests restricted immune activity.
CD38 staining in tumor tissue appears faint, indicating subtle plasma cell contributions to the tumor microenvironment.

The immunohistochemistry image of the class tumor stained with the biomarker CD38 shows a diffuse positivity with brown staining in the cytoplasm and membrane of the cells.
The IHC image reveals diffuse CD38-positive staining in tumor cells, with brown staining observed in both the cytoplasm and membrane.
CD38 staining in tumor tissue appears as a diffuse brown signal, marking its presence in the cytoplasm and membrane of cells.
A widespread CD38 staining pattern is observed in tumor cells, with strong cytoplasmic and membranous positivity.
The image presents tumor cells with diffuse CD38 staining, highlighting its presence in both cellular compartments.
CD38 expression in tumor tissue is observed as a diffuse brown staining pattern, confirming its cellular distribution.
A strong, diffuse CD38 positivity is seen in tumor cells, suggesting broad marker expression.
CD38 staining highlights tumor cells with cytoplasmic and membranous brown staining, confirming its presence.
The image captures a diffuse CD38 staining pattern, marking widespread expression in tumor cells.
CD38 expression in tumor cells is distributed throughout the cytoplasm and membrane, marking its cellular localization.
The presence of diffuse CD38 staining in tumor tissue suggests broad marker involvement in cellular processes.


The Immunohistochemistry image of the class tumor stained with the biomarker CD38 shows strong positive cytoplasmic staining of the tumor cells.
The IHC image displays intense CD38 cytoplasmic staining in tumor cells, confirming high expression levels.
CD38-positive tumor cells exhibit strong cytoplasmic staining, marking its abundant presence.
A strong immunostaining pattern for CD38 is observed in tumor cells, localized within the cytoplasm.
The image highlights tumor tissue with robust CD38-positive cytoplasmic staining.
Tumor cells present with intense CD38 cytoplasmic staining, suggesting high biomarker expression.
CD38 expression in tumor cells appears as strong brown cytoplasmic staining, confirming its presence.
The image reveals tumor cells with prominent cytoplasmic CD38 staining, supporting its role in cellular activity.
CD38 staining in tumor tissue is strongly localized to the cytoplasm, marking its expression.
A pronounced CD38 cytoplasmic staining pattern is observed in tumor cells, confirming biomarker presence.
The image presents tumor cells with strong CD38 staining, indicating its functional relevance in the tumor microenvironment.

The image shows a positive immunohistochemistry staining for CD38 in a cell, indicating the presence of CD38 biomarker.
CD38-positive staining is observed in tumor cells, confirming biomarker expression.
The image highlights a cell with positive CD38 staining, marking its expression in the tissue.
A distinct CD38-positive staining reaction is seen in the tumor, confirming the presence of the biomarker.
CD38 expression is detected in the image through a strong immunohistochemical reaction.
The presence of CD38-positive staining in a cell confirms its expression in the tissue sample.
CD38 staining appears as a positive immunohistochemical reaction in the image, confirming its cellular presence.
A single tumor cell exhibits CD38-positive staining, confirming its identification.
The image presents a clearly stained CD38-positive cell, marking biomarker localization.
CD38 staining is observed as a strong positive reaction in the immunohistochemistry image.
A positive immunohistochemistry stain for CD38 confirms the presence of this biomarker in the tissue sample.

The image shows a positive immunohistochemistry stain for CD38, a marker associated with plasma cells, indicating the presence of plasma cells in the tissue sample.
CD38-positive staining in the image confirms the presence of plasma cells in the tissue.
The image highlights plasma cells with strong CD38 staining, marking their presence in the sample.
A positive CD38 immunostaining pattern indicates plasma cell infiltration in the tissue.
CD38 expression in plasma cells is confirmed through positive immunohistochemistry staining.
The image presents plasma cells stained for CD38, confirming their identification in the tissue.
CD38-positive plasma cells are observed, marking their distribution within the sample.
A positive staining reaction for CD38 confirms plasma cell involvement in the tissue microenvironment.
The presence of CD38-positive plasma cells in the image suggests active immune cell activity.
CD38 staining highlights plasma cells, marking their functional role in the tissue sample.
A positive CD38 immunohistochemical stain confirms plasma cell identification within the tissue.